Allergan Goes After Apotex Over Combigan ANDA
Allergan Inc. has accused Apotex Inc. of infringing four patents for Combigan, marking the drugmaker's latest attempt to block a generic version of the glaucoma treatment from hitting the market....To view the full article, register now.
Already a subscriber? Click here to view full article